Add a note about this bill. Your note is for you and will not be shared with anyone.
Because you are a member of panel , your positions on legislation and notes below will be shared with the panel administrators. (More Info)
We don’t have a summary available yet.
The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on Dec 18, 2023.
Support for Patients and Communities Reauthorization Act
This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse.
This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs.
Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act.
Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.
GovTrack helps everyone learn about and track the activities of the United States Congress. Launched more than 20 years ago, we’re one of the oldest government transparency and accountability websites on the Internet.
This is a project of Civic Impulse, LLC. GovTrack.us is not a government website.